Psychedelic Stocks Archives - Page 11 of 61

TuesdayMar 12, 2024 11:00 am

2024 Could See Significant Investments in Studying Solid Tumors, Psychedelics

Experts predict that one of the key focuses for investors this year will be neuroscience and cancer-focused companies, with psychedelics being a priority within the neuroscience space. The specialists project that 2024 may be another year of significant investment in studying solid tumors and psychedelic drugs after 2023 proved to be a major year for investment in psychedelics and cancer. In addition, these researched informed BioSpace that there would be increased interest in obesity and autoimmune disorders among biopharma investors. Psychedelics have attracted plenty of attention from the mainstream and scientific communities over the past several years, thanks to their…

ThursdayMar 07, 2024 10:30 am

Okanagan Researchers Explore Whether Psychedelics Could Help Combat Alcoholism

Research has shown that psychedelics may be useful in the treatment of a range of mental-health conditions, including anxiety, depression and post-traumatic stress disorder. Now, Okanagan researchers are looking into whether psychedelics can help manage alcoholism. Okanagan Clinical Trials is among other sites in Finland and Canada taking part in this research. The researchers’ objective is to evaluate the effectiveness of psilocybin in treating alcohol use disorder. Psilocybin is the active ingredient found in hallucinogenic mushrooms. To participate in the trial, all volunteers go through screening after which they participate in 10 therapy sessions, with two of sessions including the…

TuesdayMar 05, 2024 9:30 am

Harvard, Berkeley Unveil Far-Reaching Psychedelics Initiative

Harvard University and the University of California, Berkeley have announced a collaborative venture. Titled “Psychedelics in Society and Culture,” the collaboration aims to understand the social history and societal implications of psychedelics. In a notable departure from the nascent psychedelic industry’s focus on clinical outcomes, the collaborative initiative will focus on societal sciences, humanities and arts. Psychedelic-focused initiatives mostly focus on how psychedelic use affects the human body and typically study the clinical outcomes of using psychedelics such as psilocybin (magic mushrooms), LSD and MDMA against a myriad of mental disorders. A growing body of scientific literature has found that…

ThursdayFeb 29, 2024 11:00 am

Study Finds DMT Promising in Symptomatic Relief for Depression

DMT is a potent psychedelic that has shown potential in reducing depression symptoms. This naturally occurring substance can be found in different animals and plants. When inhaled or ingested, this substance produces intense auditory and visual hallucinations. Unlike other psychedelics such a psilocybin or LSD, which produce prolonged experiences, DMT’s effects are brief, which make it a more flexible and manageable therapeutic option. A new study examined the therapeutic potential of DMT and its effects on the psychological well-being of individuals. The study used data from a pair of complementary studies that involved 30 healthy volunteers who had previously used…

TuesdayFeb 27, 2024 11:00 am

Athletes Share How Psychedelics Helped Them Overcome Life-Changing Injuries

A recent CNN report has highlighted how several athletes used psychedelics to overcome life-changing injuries and the myriad of mental-health challenges these injuries caused. Canadian Daniel Carcillo began playing professional ice hockey after graduating high school and broke into the National Hockey League (NHL) by age 20. After a decade-long career that saw him play for the Los Angeles Kings, New York Rangers and Philadelphia Flyers, Carcillo was a two-time Stanley Cup winner on the cusp of a well-earned retirement. However, he says, seven diagnosed concussions left him with headaches, anxiety, depression and “dementia-like” symptoms, rendering him suicidal. The retired…

ThursdayFeb 22, 2024 11:00 am

Psychedelics Take Different Commercialization Approach from Marijuana

The growing psychedelic industry is charting its own path to commercialization instead of following cannabis’ footprints. The psychedelics industry is basing its approach on facts and research, unlike cannabis, which centered on legalization. Experts in the psychedelic field have been conducting research on the substances for decades now, which has led to the discovery of various benefits that psychedelics hold. Researchers started studying psychedelics in the 1950s, until two decades later when the Controlled Substances Act came into effect. This act made it illegal to hold, much less carry out research on these compounds, which were classified into different schedules.…

TuesdayFeb 20, 2024 9:45 am

Researchers Look into Possibility of Treating Borderline Personality Disorder Using Psychedelics

Researchers are considering the possibility of using psychedelic drugs such as MDMA to treat Borderline Personality Disorder (BPD). BPD is a debilitating mental disorder that hinders an individual’s ability to manage emotions and leads to high impulsivity; it also generally negatively affects relationships. People with BPD often have long-term feelings of emptiness and find it difficult to form a stable sense of identity. This can result in impulsive behaviors and self-destructive tendencies, including suicidal thoughts or self-harm. Intense fear of abandonment also leads to stormy and volatile relationships characterized by devaluation and idealization of partners. Current treatment protocols for borderline…

ThursdayFeb 15, 2024 10:45 am

New Study Says Psychedelics Could Boost Sexual Function

Psychedelics such as LSD and hallucinogenic mushrooms may improve sexual function after one undergoes a psychedelic experience. Researchers are reporting the results of a new study, which they believe is the first study to look into the effects of psychedelic substances on sex. For their research, the investigators gathered survey responses from an estimated 300 participants prior to and after a psychedelic experience that involved drugs such as magic mushrooms, DMT and ayahuasca. Respondents included individuals who were taking the drugs for ceremonial, wellness or recreational purposes, as well as a small group involved in a trial that evaluated the…

TuesdayFeb 13, 2024 10:45 am

Seizures of Magic Mushrooms by Authorities Rose as Demand Grew

In the last couple of years, we have seen interest in psychedelics increase as more studies uncover their hidden benefits. Interest in psilocybin, the psychoactive compound found in hallucinogenic mushrooms, has increased significantly following evidence of its benefits for a range of mental-health conditions, including post-traumatic stress disorder and depression. However, drug busts of magic mushrooms have also increased, with data from new research showing that the amount of psilocybin seized by authorities has more than tripled in the period between 2017 and 2022. The author of this new research, Joseph Palamar, stated that the study’s findings indicated that the…

ThursdayFeb 08, 2024 10:45 am

Study Finds Psychedelic Users More Prone to Unusual Visual Experiences

Research into psychedelics has increased significantly in the recent past, with growing evidence to support their therapeutic benefits for a range of disorders, among them alcoholism and depression. Now, a new study has found that people who use psychedelics such as psilocybin and LSD may experience increased unusual visual occurrences. The study looked into the possible side effects of psychedelics when used in a recreational setting. The focus outside of clinical settings comes from concern that using these drugs in uncontrolled environments may not be safe. For their research, the scientists looked into the intensity and prevalence of visual experiences…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks